Free Silicone-Induced Deep Inferior Epigastric Perforator Flap Failure in the Setting of Silicone Mastitis

The illicit use of injectable silicone for cosmetic purposes in the breast has persisted for over five decades without support of the Food and Drug Administration (FDA)[1] and is associated with local and systemic complications.[1] [2] [3] The constellation of symptoms first described by Boo-Chai in 1969 as “silicone mastitis,”[4] stems from an inflammatory reaction to silicone and consists of pain, discoloration, and irregular nodularity. Though there are numerous reports regarding silicone mastitis,[4] [5] [6] the exact incidence is unknown. Unless confined to a localized area of the breast, the most effective treatment is mastectomy. As silicone infiltration increases the risk of tissue ischemia and infection, autologous tissue reconstruction mitigates these risks and theoretically offers a superior option compared with breast implant–based reconstruction. Various autologous reconstructions have been described,[3] [5] [7] and in the instances when free tissue transfer has failed, the source of thrombotic-related failure may be unknown.[3] [7] To the best of our knowledge, we report the first case of deep inferior epigastric perforator (DIEP) flap loss following silicone mastitis reconstruction as a result of free silicone-precipitated thrombosis.

^* Both authors contributed equally to the article.

• References

• 1 Peters W, Fornasier V. Complications from injectable materials used for breast augmentation. Can J Plast Surg 2009; 17 (03) 89-96
• 2 Coleman SR. Injectable silicone returns to the United States. Aesthet Surg J 2001; 21 (06) 576-578
• 3 Feng L-J, Mauceri K, Berger BE. Autogenous tissue breast reconstruction in the silicone-intolerant patient. Cancer 1994; 74 (1, Suppl): 440-449
• 4 Boo-Chai K. The complications of augmentation mammaplasty by silicone injection. Br J Plast Surg 1969; 22 (03) 281-285
• 5 Echo A, Otake LR, Mehrara BJ. , et al. Surgical management of silicone mastitis: case series and review of the literature. Aesthetic Plast Surg 2013; 37 (04) 738-745
• 6 Yoshida SH, Swan S, Teuber SS, Gershwin ME. Silicone breast implants: immunotoxic and epidemiologic issues. Life Sci 1995; 56 (16) 1299-1310
• 7 Mizuno H, Hyakusoku H, Fujimoto M, Kawahara S, Aoki R. Simultaneous bilateral breast reconstruction with autologous tissue transfer after the removal of injectable artificial materials: a 12-year experience. Plast Reconstr Surg 2005; 116 (02) 450-458
• 8 Lai YL, Weng CJ, Noordhoff MS. Breast reconstruction with TRAM flap after subcutaneous mastectomy for injected material (siliconoma). Br J Plast Surg 2001; 54 (04) 331-334
• 9 Chiu W-K, Lee TP, Chen SY, Li CC, Wang CH, Chen S-G. Bilateral breast reconstruction with a pedicled transverse rectus abdominis myocutaneous flap after subcutaneous mastectomy for symptomatic injected breasts. J Plast Surg Hand Surg 2012; 46 (3-4): 242-247
• 10 Saint-Cyr M, Chang DW, Robb GL, Chevray PM. Internal mammary perforator recipient vessels for breast reconstruction using free TRAM, DIEP, and SIEA flaps. Plast Reconstr Surg 2007; 120 (07) 1769-1773